Over the past 12 months, 4 insiders at Privia Health Group, Inc. filed 29 open-market SEC Form 4 transactions on PRVA: 0 purchases worth $0 and 29 sales worth $14.4M. Insiders have been net sellers over this period. The most recent filing was on Jul 9, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 9, 26 | David MountcastleEVP & Chief Financial Officer | SELL | 21.3K | $27.67 | $589K |
| Jul 7, 26 | David MountcastleEVP & Chief Financial Officer | SELL | 600 | $27.57 | $17K |
| Jul 6, 26 | Matthew Shawn Morris | SELL | 53.7K | $27.24 | $1.5M |
| Jul 2, 26 | Matthew Shawn Morris | SELL | 59.0K | $27.33 | $1.6M |
| Jul 2, 26 | David MountcastleEVP & Chief Financial Officer | SELL | 24.7K | $27.50 | $680K |
| Jul 1, 26 | Matthew Shawn Morris | SELL | 45.6K | $26.93 | $1.2M |
| Jun 30, 26 | Matthew Shawn Morris | SELL | 52.8K | $25.72 | $1.4M |
| Mar 16, 26 | Parth MehrotraChief Executive Officer | SELL | 26.5K | $22.11 | $586K |
| Mar 16, 26 | David MountcastleEVP & Chief Financial Officer | SELL | 6.4K | $22.11 | $141K |
| Mar 13, 26 | Parth MehrotraChief Executive Officer | SELL | 27.2K | $21.52 | $586K |
| Mar 13, 26 | David MountcastleEVP & Chief Financial Officer | SELL | 6.6K | $21.52 | $141K |
| Mar 12, 26 | Parth MehrotraChief Executive Officer | SELL | 26.8K | $21.90 | $586K |
| Mar 12, 26 | David MountcastleEVP & Chief Financial Officer | SELL | 6.5K | $21.90 | $141K |
| Mar 10, 26 | Parth MehrotraChief Executive Officer | SELL | 21.1K | $22.71 | $479K |
| Mar 9, 26 | Edward C FargisEVP & General Counsel | SELL | 4.9K | $22.84 | $113K |
| Mar 9, 26 | Parth MehrotraChief Executive Officer | SELL | 21.9K | $23.37 | $501K |
| Mar 9, 26 | David MountcastleEVP & Chief Financial Officer | SELL | 5.8K | $22.84 | $133K |
| Mar 6, 26 | Edward C FargisEVP & General Counsel | SELL | 4.4K | $23.15 | $102K |
| Mar 6, 26 | Parth MehrotraChief Executive Officer | SELL | 21.4K | $23.15 | $496K |
| Mar 6, 26 | David MountcastleEVP & Chief Financial Officer | SELL | 5.2K | $23.15 | $120K |
| Feb 27, 26 | Matthew Shawn MorrisDirector | SELL | 16.6K | $25.00 | $414K |
| Feb 27, 26 | David MountcastleEVP & Chief Financial Officer | SELL | 7.7K | $25.05 | $193K |
| Feb 26, 26 | Matthew Shawn MorrisDirector | SELL | 7.8K | $24.99 | $195K |
| Feb 26, 26 | David MountcastleEVP & Chief Financial Officer | SELL | 5.4K | $25.00 | $134K |
| Dec 12, 25 | Matthew Shawn MorrisDirector | SELL | 13.6K | $25.01 | $341K |
| Dec 12, 25 | David MountcastleEVP & Chief Financial Officer | SELL | 23.9K | $25.03 | $598K |
| May 13, 25 | Parth MehrotraChief Executive Officer | SELL | 15.9K | $24.52 | $390K |
| May 12, 25 | Parth MehrotraChief Executive Officer | SELL | 13.8K | $24.99 | $344K |
| May 12, 25 | David MountcastleEVP & Chief Financial Officer | SELL | 3.3K | $24.99 | $83K |
| May 1, 25 | Parth MehrotraChief Executive Officer | SELL | 17.4K | $23.08 | $401K |
| Apr 30, 25 | Parth MehrotraChief Executive Officer | SELL | 15.1K | $23.33 | $352K |
| Apr 30, 25 | Matthew Shawn MorrisDirector | SELL | 10.3K | $23.33 | $241K |
| Apr 30, 25 | David MountcastleEVP & Chief Financial Officer | SELL | 3.4K | $23.33 | $80K |
| Apr 2, 25 | David MountcastleEVP & Chief Financial Officer | SELL | 5.6K | $22.38 | $126K |
| Mar 12, 25 | Parth MehrotraChief Executive Officer | SELL | 10.5K | $24.03 | $253K |
| Mar 11, 25 | Edward C FargisEVP & General Counsel | SELL | 2.4K | $23.88 | $58K |
| Mar 11, 25 | Parth MehrotraChief Executive Officer | SELL | 9.3K | $23.88 | $222K |
| Mar 11, 25 | David MountcastleEVP & Chief Financial Officer | SELL | 2.9K | $23.88 | $69K |
| Mar 10, 25 | Edward C FargisEVP & General Counsel | SELL | 2.5K | $24.53 | $62K |
| Mar 10, 25 | Parth MehrotraChief Executive Officer | SELL | 9.6K | $24.53 | $236K |
| Mar 10, 25 | David MountcastleEVP & Chief Financial Officer | SELL | 3.0K | $24.53 | $73K |
| Feb 14, 25 | David MountcastleEVP & Chief Financial Officer | SELL | 100.0K | $25.15 | $2.5M |
| Sep 10, 24 | Parth MehrotraChief Executive Officer | SELL | 135.1K | $18.50 | $2.5M |
| Jun 11, 24 | Adam BoehlerDirector | BUY | 364 | $16.50 | $6K |
| May 29, 24 | Adam BoehlerDirector | BUY | 5.3K | $16.50 | $88K |
| May 24, 24 | Adam BoehlerDirector | BUY | 4.3K | $16.49 | $71K |
| May 23, 24 | Thomas A McCarthyDirector | BUY | 10.0K | $16.37 | $164K |
| May 23, 24 | Adam BoehlerDirector | BUY | 172.6K | $16.28 | $2.8M |
| May 22, 24 | Adam BoehlerDirector | BUY | 102.2K | $16.43 | $1.7M |
| May 21, 24 | Adam BoehlerDirector | BUY | 277.6K | $16.17 | $4.5M |
Over the past 12 months, insiders at Privia Health Group, Inc. filed 0 open-market purchases worth $0 and 29 sales worth $14.4M on PRVA, which makes them net sellers over the period. The most recent Form 4 was filed on Jul 9, 26.
The largest recent open-market PRVA insider purchase in our data was $4.5M by Adam Boehler, Director, filed on May 21, 24.
4 different insiders at Privia Health Group, Inc. filed open-market SEC Form 4 transactions on PRVA over the last 12 months.
InsiderTape plots every PRVA insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Privia Health Group, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →